Cagrilintide is a long-acting amylin analogue designed to regulate appetite and energy balance. As an amylin receptor agonist, it mimics the effects of the natural hormone amylin, which works alongside insulin to slow gastric emptying, promote satiety, and reduce food intake. In research, Cagrilintide has been studied for its impact on weight management, metabolic regulation, and synergy with GLP-1 receptor agonists.
Key Benefits:
- Supports studies on appetite regulation and satiety signaling.
- Contributes to research on weight management and obesity treatment.
- Explored for synergistic effects with GLP-1 agonists in metabolic health.
- Aids investigations into glucose homeostasis and insulin sensitivity.
- Provides insights into long-acting amylin receptor agonist therapies.
Purity Assurance
Every peptide we offer undergoes rigorous testing to ensure research-grade purity. Our claims are backed by regular in-house & third-party batch testing, assuring the highest quality standards.
This product is for research purposes only. It is intended exclusively for in vitro testing and laboratory experiments. All information provided on this website is for educational purposes and is not intended for human or animal use. The introduction of this product into the body, whether by ingestion, injection, or any other means, is strictly prohibited by law. Only licensed and qualified professionals should handle this product. It is not a drug, food, or cosmetic and must not be mislabeled, misused, or marketed as such.
